Ulrich Hamann

Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy

Oliver J. Stoetzer, Debora M.I. Fersching, Christoph Salat et al. · Tumor Biology · 2012 · 82 citations

Medicine, Oncology, Cancer Immunology +16

Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin

Oliver J. Stoetzer, Debora M.I. Fersching, Christoph Salat et al. · Cancer Letters · 2013 · 54 citations

Medicine, Cancer Biology, Oncology +17

Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry

D. Hölzel, Renate Eckel, Ingo Bauerfeind et al. · Journal of Cancer Research and Clinical Oncology · 2017 · 52 citations · Full text

Medicine, Biomedical Sciences, Oncology +17

Survival of de novo stage IV breast cancer patients over three decades

D. Hölzel, Renate Eckel, Ingo Bauerfeind et al. · Journal of Cancer Research and Clinical Oncology · 2016 · 39 citations · Full text

Medicine, Oncology, Surgery +12

Quality of life in breast cancer patients and surgical results of immediate tissue expander/implant-based breast reconstruction after mastectomy

Moritz Hamann, M Brunnbauer, Heike Scheithauer et al. · Archives of Gynecology and Obstetrics · 2019 · 21 citations

Medicine, Plastic Surgery, Surgery +16